Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
NCT: NCT04782830 · RECRUITING
Brief Summary
The objective of this study is to find a more objective and accurate way to assess the efficacy of the treatment for neurogenic orthostatic hypotension. For this purpose, the investigators will use an activity monitor to determine the amount of time patients spend in the upright position (standing and walking; upright time) during 1 week of placebo (a pill with no active ingredients) and 1 week of their regular medication for orthostatic hypotension (midodrine or atomoxetine at their usual doses). Total upright time (i.e. tolerance to standing and walking) will be compared between placebo and active treatment to test the hypothesis that it can be used to assess the efficacy of the treatment for orthostatic hypotension and whether this outcome is superior to the assessment of symptoms using validated questionnaires.
Frequently Asked Questions
What is Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms?
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms is a clinical trial registered under NCT04782830. Current status: RECRUITING.
What is the status of NCT04782830?
The current status of NCT04782830 (Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms) is: RECRUITING.
When did Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms start?
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms started on 2021-02-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.